My mom was diagnosed with stage 3 cholangiocarcinoma in December. She had the Whipple surgery early January. Two...

CholangiocarcinomaNovember 13, 2026Written by Navis AI

Understanding the CA 19-9 Rise Without Visible Recurrence

What This Pattern Can Mean:

The rising CA 19-9 (from 45 to 714) despite "no recurrence" on imaging is actually a recognized clinical scenario that requires careful investigation. Here's what oncologists typically consider:

  1. Microscopic Disease - Cancer cells may be present but too small to detect on current imaging. CT and MRI scans generally can't see tumors smaller than 5-10mm. According to NCCN Guidelines, rising tumor markers often precede visible disease by several months.

  2. Peritoneal Involvement - The "moderate fluid in stomach" (likely peritoneal/ascitic fluid) mentioned on the scan, combined with bloating, raises concern for peritoneal carcinomatosis (cancer spread to the abdominal lining). This can be difficult to see clearly on standard imaging and may explain:

    • The fluid that appeared then "disappeared"
    • Rising CA 19-9
    • Bloating and abdominal discomfort
    • Feeling full quickly (called early satiety)
  3. Benign Causes of CA 19-9 Elevation - While less likely given the dramatic rise, CA 19-9 can increase due to:

    • Bile duct obstruction or inflammation
    • Pancreatitis
    • Liver dysfunction
    • Cholangitis (bile duct infection)

The Fluid Mystery:

The discrepancy between "moderate fluid" on imaging and "no fluid" at the drainage attempt is concerning and needs explanation. Possibilities include:

  • Timing/Position Changes - Fluid can shift or be reabsorbed, though 2 weeks is relatively quick
  • Imaging Interpretation - What appeared as fluid might have been bowel loops or other structures
  • Loculated Fluid - Fluid trapped in pockets that's hard to access with a needle
  • Omental Caking - Thickening of abdominal tissue that can look like fluid on scans

Tell us what’s going on with cholangiocarcinoma. 2 free answers, then a free account.

What Your Mom's Symptoms Suggest

Her symptoms are significant and shouldn't be dismissed:

Bloating + Early Satiety + Pain + Rising CA 19-9 = Needs Investigation

According to NCCN Guidelines for cholangiocarcinoma, these symptoms warrant:

  1. Repeat Imaging with Specific Focus:

    • Dedicated peritoneal protocol CT or MRI
    • PET/CT scan (can detect metabolically active disease that structural imaging misses)
    • Consider diagnostic laparoscopy if imaging remains unclear
  2. Additional Blood Work:

    • CEA (carcinoembryonic antigen) - another tumor marker
    • Liver function tests
    • Complete metabolic panel
  3. Symptom Management:

    • Evaluation for partial bowel obstruction
    • Assessment for ascites (abdominal fluid)
    • Gastric emptying studies if needed

Critical Questions to Ask Her Oncologist

About the CA 19-9:

  1. "Given the CA 19-9 has nearly tripled since the low point, what additional imaging or tests do you recommend to find where disease might be hiding?"

  2. "Should we get a PET/CT scan to look for metabolically active disease that might not show up on regular CT?"

  3. "Is diagnostic laparoscopy an option to directly visualize the peritoneal cavity and sample any fluid or tissue?"

  4. "What CA 19-9 trend would prompt you to change treatment, even without visible disease on scans?"

About the Fluid/Symptoms:

  1. "The scan showed moderate fluid, but none was found at drainage. Can we repeat imaging specifically looking at the peritoneum and get a second radiologist opinion?"

  2. "Could her symptoms (bloating, early satiety, pain) indicate peritoneal disease even if we can't see it clearly yet?"

  3. "Should we consider a diagnostic paracentesis (fluid sampling) under ultrasound guidance to ensure we're checking the right location?"

About Treatment:

  1. "Given the rising tumor marker, should we consider changing or intensifying chemotherapy now rather than waiting for visible disease?"

  2. "Are there clinical trials available for cholangiocarcinoma with rising markers but no measurable disease?"

  3. "What's the plan if the CA 19-9 continues rising but scans remain negative?"

What Typically Happens Next (Clinical Framework)

According to NCCN Guidelines, when tumor markers rise significantly after treatment:

Standard Approach:

  • Repeat imaging within 4-8 weeks with enhanced protocols
  • Consider PET/CT if not already done
  • May proceed with treatment change based on markers alone if rise is dramatic and sustained
  • Diagnostic laparoscopy for suspected peritoneal disease

Treatment Options for Rising Markers:

  • Change chemotherapy regimen (second-line therapy)
  • Clinical trial enrollment
  • Targeted therapy if biomarker testing shows actionable mutations (FGFR2, IDH1, etc.)

Important Context About Post-Whipple Changes

Some bloating and digestive changes are normal after Whipple surgery due to:

  • Altered anatomy
  • Delayed gastric emptying
  • Pancreatic enzyme insufficiency

However, the combination of worsening symptoms + rising CA 19-9 + fluid on imaging suggests this is more than post-surgical adjustment.

My Recommendation

This situation requires urgent clarification. The rising CA 19-9 is a red flag that shouldn't be ignored, even with negative imaging. Request:

  1. Multidisciplinary tumor board review of her case
  2. PET/CT scan if not recently done
  3. Repeat imaging with peritoneal protocol
  4. Second opinion from a cholangiocarcinoma specialist at an NCCN Cancer Center if not already at one

The goal is to either:

  • Find and treat disease that's currently hiding, OR
  • Definitively rule out active disease and address the CA 19-9 rise through other means

Don't let the "no recurrence" scan result delay investigation when the tumor marker and symptoms are telling a different story.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your next question, already answered

Tap to keep going. 2 free answers, then a free account.

Ask Navis about your case

That answer is general. Ask about your specific situation. Answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

  • Built by OpenCancer’s team of physician-scientists and cancer survivors.
  • Last updated November 13, 2026. Informational only — not a substitute for your oncology team.

Question asked:

My mom was diagnosed with stage 3 cholangiocarcinoma in December. She had the Whipple surgery early January. Two lymph nodes were positive. She started chemo shortly after surgery and then had 25 rounds of radiation. Before surgery her CA 19-9 was close to 200. After surgery it was 77, then towards the end of radiation it went down to 45. Since then her CA 19-9 has jumped from 200, 499 to 714. She had her scan about 2 weeks ago and got the results back, no recurrence or growth, but had moderate fluid in her stomach so they wanted her to get the fluid tested to see if it could be cancer cells. When she went to get this done they told her there wasn't any fluid in her stomach and that it could have gone away from the time she was scanned or that maybe the scan was wrong. My mom's stomach has looked really bloated since the end of her radiation treatments and when she eats she said her stomach hurts because she feels so full and other times her stomach will just randomly hurt. What could a rising CA 19-9 with no recurrence on scan mean, and what could be causing the bloating and stomach pain?

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

More questions about Cholangiocarcinoma